therapy of severe alcoholic hepatitis€¦ · alcoholic hepatitis •alcoholic steatohepatitis...
TRANSCRIPT
Felix Stickel
Department of Clinical Research - Hepatology, University of Berne
&
Hepatology Unit, Klinik Beau-Site, Hirslanden Berne;
Switzerland
Therapy of Severe Alcoholic Hepatitis
VII Workshop Internacional de Atulização em Hepatologia, Curitiba 2014
Case report
• 46-year old male Arab patient, owner of construction company,
married, 3 sons, 1 daughter
• 19.11.2013 presentation with declining physical strength since 3 weeks,
jaundice, bilateral leg edema, weight gain (+11kg/2 weeks), abdominal
distension; temperature 37.9°C, pulse 106/min, RR 109/76 mmHg
• Spider angiomata, palmar erythema, no flap, no hepatic fetor,
significant ascites, BMI 31.3 kg/m2 (doubtful – ascites!)
• Loss of appetite since 12 months, poor food intake, alcohol ¾ bottle of
Scotch Whisky/day, nicotine 1 ½ packs/day (30 pys)
• Sigmoid resection 2004 for perforated diverticulitis;
arterial hypertension, amlodipine 5mg od since 2 years
Case report Laboratory
AST (U/L), ULN 35 167
ALT (U/L), ULN 35 66
gGT (U/L), ULN 40 242
Bilirubine (mmol/l), ULN 20 76
Albumine (g/L), NR 35-50 22.4
INR (NR 0.9-1.2) 2.28
Hemoglobin, g/L, NR 120-154 110
Leucocytes, 4-9 17.0
MCV, 81-99 96 fL
Sodium (mmol/L), NR 136-144 126
What else do you want to know?
Case report Laboratory
Creatinine (mmol/L), NR 44-83 507
CRP (mg/L), ULN 5 34.7
Ceruloplasmin, g/L, NR 0.2-0-6 0.42
Ferritin (mg/L), NR 11-310 442
Transferrin saturation, ULN 35% 43
Glucose (mmol/L), NR 4.1-6.6 6
Potassium (mmol/L), NR 3.6-5.1 4.9
Negative findings for Hepatitis A/B/C/E, HIV,
Autoantibodies, normal levels of Ig‘s, CDT
What‘s next?
Case report - Ultrasound
4.5cm
10.9cm
What‘s the likely diagnosis?
A Decompensated alcoholic cirrhosis with hepatorenal failure
Why not: Spleen normal, rapid evolution of symptoms and signs
B Chronic alcoholic liver damage with acute-on-chronic drug-induced liver
injury
Why not: amlodipine longer than 6 mo (and rare anyway)
C Alcoholic liver disease complicated by acute severe alcoholic hepatitis and
subsequent hepatorenal failure
Why not: no reason why not…
D Acute-on-chronic alcoholic liver disease precipitated by occult GI bleeding
and/or infection
Why not: no reason why not…
Screening for GI-bleeding and infections
Varices grade I Rectal polyp
inapparent No UTI
Alcoholic hepatitis
• Alcoholic steatohepatitis (ASH) present in
~20% of patients with ALD undergoing
biopsy
• Severe ASH less frequent
• Clinical picture: sudden onset of jaundice in
a drinker with fever, signs of impaired liver
function, right upper quadrant pain
• Mortality high in severe cases (40%) and
even higher in those unresponsive to
therapy (>80%)
Can we establish the working diagnosis of severe alcoholic
hepatitis based on information already available?
Yes, we even should, because of
Clinical presentation highly suspicious
Emergency situation (renal failure)
Non-invasive severity scores available
EASL Clinical Practice Guidelines J Hepatol 2012;57:399-20
MELD 33
Transjugular liver biopsy
Steatosis
Cholestasis
Ballooning
Neutrophilic infiltrate
Lymphocytic infiltrate
Alcoholic hepatitis – medical treatments
• Glucocorticosteroids + (DF≥32)
• Total enteral nutrition +
• Anti-TNFa biologicals -
• Pentoxifylline -/+ (HRS)
• N-acetylcysteine -/+ (28 days)
Corticosteroids in (severe) ASH
Cabré et al, Hepatology 32, 36, 2000
intention to treat
Alcoholic hepatitis – role of total enteral nutrition (TEN)
Pentoxifylline in severe ASH
Lebrec et al. Gastroenterology 2010;138:1755-62
N=164
N=171
Prednisolone and Pentoxifylline in severe ASH
Mathurin et al. JAMA 2013;310:1033-41
N=137
N=133
Prednisolone + N-acetylcysteine in severe ASH
Prednisolone + NAC N=85
N=89 Prednisolone + NAC N=89
P=0.006
P=0.06
P=0.07 (log rank)
Nguyen-Khac et al. N Engl J Med 2011;365:1781-9
Mortality of severe ASH
Louvet et al Hepatology 2007
Responders
Non-responders
The Lille Model – predicting survival according to therapy response
Louvet et al. Hepatology 2007
Age
Albumin (day 0)
Bilirubin (day 0 vs 7)
Renal function
Coagulation (day 0)
http://www.lillemodel.com/score.asp
What can we offer to non-responders?
Aims
• To determine whether early liver transplantation in non-responders to medical therapy improves 6-month survival
• To evaluate alcohol relapse
Patients (n=26)
• Subjects with first episode of ASH
• Non responsive to steroid (40mg
prednisolone) as defined by a Lille score ≥0.45
or worsening of liver function by day 7
• Strict selection criteria:
- absolute consensus of paramedical and medical staff
- no co-morbidities
- social integration
- supportive family members
- psychiatric evaluation and addictive profile
Background
• Patients with severe ASH non-responsive to steroid treatment have a mortality >80%
• The 6-months rule precludes such patients from OLT listing
Male no. [%] 15 [57.7%]
Age (y) median [95%CI] 47.4 [42.7-52.4]
Corticosteroids treatment (d) Median [95%CI] 11.5 [7-18]
Hepatorenal syndrome, no. [%] 15 [57.7%]
Hemofiltration/MARS® [%] 10 [38.5 %]
Infection before transplantation no [%] 18 [69.2%]
Mathurin P, N Engl J Med 2011;365:1790-1800
Results
• No alcohol relapse within the 6 month period
• 3 patients resumed alcohol consumption during
data collection at 720, 740 and 1140 days
• Despite counseling, 2 patients remained daily
consumers (30 g/day and > 50 g/, respectively)
whereas 1 had occasional consumption
(approximately 10g/week)
Mathurin P, N Engl J Med 2011;365:1790-1800
Outcomes of OLT in Alcoholic Cirrhotics and ASH are similar
Graft survival
Patient survival
Graft survival
Singal AK, Hepatology 2012;55:1398-1405
NS
NS
I‘ve stopped drinking, but only while I‘m asleep
George Best, Manchester United
Outcome of patient I.A.
• Hepatorenal syndrome: Terlipressin + Albumin, later to switch to
Noradrenalin + Albumin (hemodynamic monitoring); gradual recovery
of renal function
• Start with Prednisolone 40mg + Pentoxifyllin 3x400mg
• Referral to transplant unit for assessment of eligibility for living donor
transplantation (son at age of 22 years)
• Assessment of Lille model at day 7 of corticosteroids: 0.072 – complete
responder, continuation of steroids for 28 days, and subsequent taper
for 14 days until stop
• One episode of spontaneous bacterial peritonitis, one urinary tract
infection (both treated with antibiotics)
• Full recovery with near-normal liver function (June 2014), non-drinking
Conclusion
• Severe alcoholic steatohepatitis is a relatively infrequent complication
in alcoholics but has a grave prognosis
• Early diagnosis and assessment of eligibility for corticosteroide therapy
is pivotal and well-evaluated scores are available
• Liver biopsy can be usefuly, but is not imperative
• Exclusion of severe (and occult hepatitis B) infections is mandatory
• Response to corticosteroid therapy can be assessed by the Lille model
which should be used for detecting responders, and particularly non-
responders
• Non-responders may be candidates for liver transplantation